Fee-for-service remains the primary driver of patient revenue for the majority of oncology practices across the country, and the same is true for The Center for Cancer and Blood Disorders.
David Wheeler, CPA, MBA
Advertisement
Articles by David Wheeler, CPA, MBA
Advertisement
Latest Updated Articles
Dipping a Toe Into Care ManagementOctober 16th 2016
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Capivasertib Plus Abiraterone and Prednisone for PTEN-Deficient mHSPC
2
Luspatercept Misses Primary RBC-TI End Point But Shows Clinically Meaningful Improvement for Anemia in Myelofibrosis
3
FDA Approves Adjuvant Belzutifan Plus Pembrolizumab in ccRCC
4
MONUMENTAL-3 Data Support Talquetamab Plus Daratumumab ± Pomalidomide as a New SOC in R/R Myeloma
5